Related references
Note: Only part of the references are listed.The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials
Jun-Jie Yin et al.
BIOMATERIALS (2009)
High Cytotoxicity of Cisplatin Nanocapsules in Ovarian Carcinoma Cells Depends on Uptake by Caveolae-Mediated Endocytosis
Irene H. L. Hamelers et al.
CLINICAL CANCER RESEARCH (2009)
The Role of the Mammalian Copper Transporter 1 in the Cellular Accumulation of Platinum-Based Drugs
Christopher A. Larson et al.
MOLECULAR PHARMACOLOGY (2009)
Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy
Sudipta Basu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy
Matthew D. Hall et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
How do real tumors become resistant to cisplatin?
Piet Borst et al.
CELL CYCLE (2008)
Biopharmaceutics and Therapeutic Potential of Engineered Nanomaterials
Xing-Jie Liang et al.
CURRENT DRUG METABOLISM (2008)
Hydrochalarones: A novel endohedral metallofullerene platform for enhancing magnetic resonance imaging contrast
Darren K. MacFarland et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
The strong MRI relaxivity of paramagnetic nanoparticles
Gengmei Xing et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2008)
Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger
Jun-Jie Yin et al.
MOLECULAR PHARMACOLOGY (2008)
Nanoparticle-mediated cellular response is size-dependent
Wen Jiang et al.
NATURE NANOTECHNOLOGY (2008)
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Eric A. Murphy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles
Shanta Dhar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A dominant-negative form of the major human abasic endonuclease enhances cellular sensitivity to laboratory and clinical DNA-damaging agents
Daniel R. McNeill et al.
MOLECULAR CANCER RESEARCH (2007)
Periodical variation of electronic properties in polyhydroxylated metallofullerene materials
Jun Tang et al.
ADVANCED MATERIALS (2006)
Antioxidative function and biodistribution of [Gd@C82(OH)22]n nanoparticles in tumor-bearing mice
JX Wang et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Endocytic recycling compartments altered in cisplatin-resistant cancer cells
XJ Liang et al.
CANCER RESEARCH (2006)
Abnormal lysosomal trafficking and export of cisplatin in drug-resistant ovarian carcinoma cells
R Safaei et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Multi hydroxylated [Gd@C82(OH)22]n nanoparticles:: Antineoplastic activity of high efficiency and low toxicity
CY Chen et al.
NANO LETTERS (2005)
Destroying gadofullerene aggregates by salt addition in aqueous solution of Gd@C60(OH)x and Gd@C60[C(COOH2)]10
S Laus et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Trafficking and localization of platinum complexes in cisplatin-resistant cell lines monitored by fluorescence-labeled platinum
XJ Liang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Influences of structural properties on stability of fullerenols
GM Xing et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2004)
Highly selective toxic and proapoptotic effects of two dimeric ribonucleases on thyroid cancer cells compared to the effects of doxorubicin
D Spalletti-Cernia et al.
BRITISH JOURNAL OF CANCER (2004)
Identification of cytoskeletal [14C]carboplatin-binding proteins reveals reduced expression and disorganization of actin and filamin in cisplatin-resistant cell lines
DW Shen et al.
MOLECULAR PHARMACOLOGY (2004)
A pleiotropic defect reducing drug accumulation in cisplatin-resistant cells
XJ Liang et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
First soluble M@C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent
RD Bolskar et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
DNA damage measured by liquid chromatography-mass spectrometry in mouse fibroblast cells exposed to oxidative stress
JB Dawidzik et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2003)
Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines
SS Chauhan et al.
BRITISH JOURNAL OF CANCER (2003)
Lanthanoid endohedral metallofullerenols for MRI contrast agents
H Kato et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Improved extraction of metallofullerenes with DMF at high temperature
BY Sun et al.
CARBON (2002)
Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents
M Mikawa et al.
BIOCONJUGATE CHEMISTRY (2001)
HMG-CoA reductase inhibitors in the prevention of stroke
AHM van Mil et al.
DRUGS (2000)
Share Paper
